WS07.4 Effect of ivacaftor on airway bacterial community composition in CF patients with the G551D mutation
Mooney, D, Ronan, N.J, Einarsson, G, Flanagan, E.T, Eustace, J.A, Tunney, M.M, Elborn, J.S, Plant, B.J
Published in Journal of cystic fibrosis (01.06.2016)
Published in Journal of cystic fibrosis (01.06.2016)
Get full text
Journal Article
157 Ivacaftor does not produce a significant change in anti-Pseudomonas aeruginosa antibodies
Collins, A, Ronan, N.J, McCarthy, Y, Daly, M, Shortt, C, McCarthy, M, Fleming, C, Howlett, C, Hickey, C, Murphy, D.M, Plant, B.J
Published in Journal of cystic fibrosis (01.06.2017)
Published in Journal of cystic fibrosis (01.06.2017)
Get full text
Journal Article
232 Lumacaftor/Ivacaftor is associated with a significant improvement in walk test and reduction in sweat chloride in a cohort of homozygous F508del CF patients with severe disease – a single centre experience
Ronan, N.J, McCarthy, Y, James, K, Arooj, P, Hunt, E.B, Shortt, C, Fleming, C, McCarthy, M, Howlett, C, Hickey, C, Flanagan, E, Daly, M, Eustace, J.A, Maher, M.M, Plant, B.J
Published in Journal of cystic fibrosis (01.06.2017)
Published in Journal of cystic fibrosis (01.06.2017)
Get full text
Journal Article
WS04.3 A comparison of Toll-like receptor mediated innate immune response in children with cystic fibrosis and an age matched control cohort
Ronan, N.J, Harrison, M.J, Wurfel, M, Goss, C, Shanahan, F, O'Callaghan, G, O'Donovan, D, Jennings, R, Murphy, C, Keating, E, Chroinin, M. Ni, Murphy, D.M, Mullane, D, Eustace, J.A, Plant, B.J
Published in Journal of cystic fibrosis (01.06.2016)
Published in Journal of cystic fibrosis (01.06.2016)
Get full text
Journal Article
217 Medical outcomes post transition of clinical care from a paediatric cystic fibrosis care model to an adult cystic fibrosis care model – an Irish perspective
Thornton, K.P, Ronan, N.J, Shortt, C, McCarthy, M, Fleming, C, Daly, M, Hickey, C, Howlett, C, Flanagan, E.T, Eustace, J.A, Murphy, D.M, Plant, B.J
Published in Journal of cystic fibrosis (01.06.2016)
Published in Journal of cystic fibrosis (01.06.2016)
Get full text
Journal Article
WS03.3 A longitudinal, multi-centre investigation into the gut microbiota of adult CF patients – the CFMATTERS perspective
Fouhy, F, Ronan, N.J, McCarthy, Y, Arooj, P, Daly, M, Flanagan, E.T, Deane, J, O'Sullivan, O, Murphy, K, Fleming, C, McCarthy, M, Shortt, C, Eustace, J.A, Shanahan, F, Rea, M.C, Ross, R.P, Floto, R.A, Harrison, M.J, Haworth, C.S, Dupont, L, Stanton, C, Plant, B.J
Published in Journal of cystic fibrosis (01.06.2017)
Published in Journal of cystic fibrosis (01.06.2017)
Get full text
Journal Article
WS07.6 Investigating the gut microbiota of patients with cystic fibrosis (PWCF) and the effects of an altered gut microbiota on functionality and faecal metabolites – the CFMATTERS experience
Fouhy, F, Ronan, N.J, O'Sullivan, O, Deane, J, McCarthy, Y, Murphy, K, Murphy, D.M, Daly, M, Flanagan, E.T, O'Callaghan, G, Fleming, C, McCarthy, M, Shortt, C, Eustace, J.A, Shanahan, F, Rea, M.C, Ross, R.P, Stanton, C, Plant, B.J
Published in Journal of cystic fibrosis (01.06.2016)
Published in Journal of cystic fibrosis (01.06.2016)
Get full text
Journal Article
128 The metabolic consequences of CFTR modulation with ivacaftor in a single adult cystic fibrosis centre cohort
Ronan, G, Ronan, N.J, Shortt, C, Fleming, C, Cronin, K, McCarthy, M, Hickey, C, Murphy, D.M, Eustace, J.A, O'Halloran, D.J, Plant, B.J
Published in Journal of cystic fibrosis (01.06.2015)
Published in Journal of cystic fibrosis (01.06.2015)
Get full text
Journal Article
WS13.2 The role of PGE2 in cystic fibrosis (CF) lung inflammation and the potential association with ivacaftor therapy and treatment response
O'Callaghan, G.P, Ronan, N.J, Foley, N, Lyons, C, O'Driscoll, A, Ni Chroinin, M, Mullane, D, Murphy, D, Shanahan, F, Eustace, J.A, Houston, A, Plant, B.J
Published in Journal of cystic fibrosis (01.06.2015)
Published in Journal of cystic fibrosis (01.06.2015)
Get full text
Journal Article
WS16.1 Clinical Outcomes of Real-World Kalydeco (CORK) study – Investigating the impact of CFTR potentiation on the intestinal microbiota, exocrine pancreatic function and intestinal inflammation prospectively over 12 months
Deane, J, Ronan, N.J, O'Callaghan, G.P, Fouhy, F, Rea, M.C, O'Sullivan, O, Hill, C.J, Shanahan, F, Ross, R.P, McCarthy, M, Murphy, D.M, Eustace, J.A, Stanton, C, Plant, B.J
Published in Journal of cystic fibrosis (01.06.2015)
Published in Journal of cystic fibrosis (01.06.2015)
Get full text
Journal Article
WS20.4 Clinical outcomes of Real-World Kalydeco (CORK) study – a prospective 12 month analysis addressing the impact of CFTR modulation on the cystic fibrosis lung
Ronan, N.J, O'Callaghan, G.P, Mooney, D, Einarsson, G, Elborn, J.S, Ni Chroinin, M, Mullane, D, Murphy, D.M, O'Connor, O.J, Shortt, C, Tunney, M.M, Twomey, M, Maher, M.M, Eustace, J.A, Plant, B.J
Published in Journal of cystic fibrosis (01.06.2015)
Published in Journal of cystic fibrosis (01.06.2015)
Get full text
Journal Article
37 Clinical outcomes of real world Kalydeco (CORK) study
Ronan, N.J, O'Callaghan, G, Harrison, M.J, Shortt, C, McCarthy, M, Hickey, C, Fleming, C, Cronin, K, Jennings, R, O'Donovan, D, Shanahan, P, Chroinin, M. Ni, Murphy, D.M, Mullane, D, Plant, B.J
Published in Journal of cystic fibrosis (01.06.2014)
Published in Journal of cystic fibrosis (01.06.2014)
Get full text
Journal Article
P257 Who’s talking about cystic fibrosis continued: the effects of the COVID-19 pandemic on the cystic fibrosis online landscape
Ibrahim, H., Vagg, T., Ronan, N.J., McCarthy, M., Fleming, C., Dorgan, J., McCarthy, Y., Tabirca, S., Plant, B.J.
Published in Journal of cystic fibrosis (01.06.2022)
Published in Journal of cystic fibrosis (01.06.2022)
Get full text
Journal Article
P097 Who's talking about cystic fibrosis? The changing landscape of internet postings related to cystic fibrosis: a two-year comparative study
Vagg, T., Ronan, N.J., Morrissy, D., McCarthy, M., Fleming, C., McCarthy, Y., Tabirca, S., Plant, B.J.
Published in Journal of cystic fibrosis (2021)
Published in Journal of cystic fibrosis (2021)
Get full text
Journal Article
Ultra-low-dose thoracic CT with model-based iterative reconstruction (MBIR) in cystic fibrosis patients undergoing treatment with cystic fibrosis transmembrane conductance regulators (CFTR)
Moloney, F., Kavanagh, R.G., Ronan, N.J., Grey, T.M., Joyce, S., Ryan, D.J., Moore, N., O'Connor, O.J., Plant, B.J., Maher, M.M.
Published in Clinical radiology (01.05.2021)
Published in Clinical radiology (01.05.2021)
Get full text
Journal Article
WS16.6 Human epididymis protein 4 (HE4) plasma levels inversely correlate with improved FEV1 in cystic fibrosis patients under ivacaftor therapy as a new sensitive treatment efficacy biomarker
Nagy, B., Bene, Z., Fejes, Z., Heltshe, S.L., Ronan, N.J., Joseloff, E., Kappelmayer, J., Macek, M., Bell, S.C., Plant, B.J., Amaral, M.D., Balogh, I.
Published in Journal of cystic fibrosis (01.06.2018)
Published in Journal of cystic fibrosis (01.06.2018)
Get full text
Journal Article
WS13.2 The role of PGE 2 in cystic fibrosis (CF) lung inflammation and the potential association with ivacaftor therapy and treatment response
O'Callaghan, G.P., Ronan, N.J., Foley, N., Lyons, C., O'Driscoll, A., Ni Chroinin, M., Mullane, D., Murphy, D., Shanahan, F., Eustace, J.A., Houston, A., Plant, B.J.
Published in Journal of cystic fibrosis (01.06.2015)
Published in Journal of cystic fibrosis (01.06.2015)
Get full text
Journal Article